Financhill
Back

Viking Therapeutics Stock Price Chart

  • The current trend is moderately bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

Viking Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 65.42 Sell
20-day SMA: 71.69 Sell
50-day SMA: 66.5 Sell
200-day SMA: 28.15 Buy
8-day EMA: 66 Sell
20-day EMA: 68.39 Sell
50-day EMA: 62.47 Buy
200-day EMA: 36.26 Buy

Viking Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.9 Sell
Relative Strength Index (14 RSI): 44.92 Sell
Chaikin Money Flow: -1551353 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.94 - 77.68) Sell
Bollinger Bands (100): (17.62 - 69.52) Buy

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Viking Therapeutics Stock

Is Viking Therapeutics Stock a Buy?

VKTX Technical Analysis vs Fundamental Analysis

Buy
53
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics a Buy or a Sell?

Viking Therapeutics Stock Info

Market Cap:
6.54B
Price in USD:
65.07
Share Volume:
2.51M

Viking Therapeutics 52-Week Range

52-Week High:
99.41
52-Week Low:
8.28
Buy
53
Viking Therapeutics (VKTX) is a Buy

Viking Therapeutics Share Price Forecast

Is Viking Therapeutics Stock a Buy?

  • Viking Therapeutics share price is 65.07 while VKTX 8-day exponential moving average is 66.00, which is a Sell signal.
  • The stock price of VKTX is 65.07 while Viking Therapeutics 20-day EMA is 68.39, which makes it a Sell.
  • Viking Therapeutics 50-day exponential moving average is 62.47 while VKTX share price is 65.07, making it a Buy technically.
  • VKTX stock price is 65.07 and Viking Therapeutics 200-day simple moving average is 36.26, creating a Buy signal.

Fundamental Analysis of Viking Therapeutics

Is Viking Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.13 per share, and a decrease next year of $0.47 per share.

Technical Analysis of Viking Therapeutics

Should I short Viking Therapeutics stock?

* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.